Inhibition of the induction of cancer by antioxidants

T J Slaga1

  • 1University of Texas, M.D. Anderson Cancer Center, Science Park-Research Division, Smithville 78757, USA.

Insights

Antioxidants can inhibit cancer development by interfering with free radicals. This study shows antioxidants are effective in preventing skin tumor initiation, promotion, and progression.

Area of Science:

  • Oncology
  • Biochemistry
  • Free Radical Biology

Background:

  • Free radicals are implicated in all stages of chemical carcinogenesis.
  • Carcinogens and tumor promoters can decrease cellular antioxidant enzyme activity (superoxide dismutase, catalase).
  • Antioxidants may counteract these effects, potentially inhibiting cancer development.

Purpose of the Study:

  • To investigate the inhibitory effects of various antioxidants on skin tumor initiation, promotion, and progression.
  • To explore the mechanisms underlying antioxidant activity in chemical carcinogenesis.
  • To identify specific antioxidants effective at different stages of skin tumor development.

Main Methods:

  • Testing of antioxidants including BHT, vitamins E and C, CuDIPS, BHA, parahydroxyanisole, disulfiram, glutathione, and N-acyl dehydroalamines.
  • Assessment of inhibition of 7,12-dimethylbenz[a]anthracene (DMBA) skin tumor initiation.
  • Evaluation of inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA) and benzoyl peroxide-induced skin tumor promotion.
  • Analysis of effects on skin tumor progression, including the role of glutathione and gamma-glutamyl transpeptidase (GGT).

Main Results:

  • BHT, vitamin E, vitamin C, and CuDIPS inhibited DMBA skin tumor initiation by approximately 50%.
  • Antioxidants were more effective inhibitors of skin tumor promotion, with BHT, BHA, parahydroxyanisole, disulfiram, vitamin E, and vitamin C inhibiting TPA and benzoyl peroxide promotion by over 90%.
  • Glutathione and N-acyl dehydroalamines were most effective in reducing carcinoma incidence during progression; diethyl maleate and GGT overexpression enhanced progression by reducing glutathione levels.

Conclusions:

  • Antioxidants demonstrate significant inhibitory effects on skin tumor initiation, promotion, and progression.
  • The efficacy of antioxidants varies depending on the stage of carcinogenesis and the specific carcinogen/promoter involved.
  • Modulating glutathione levels and GGT activity may represent therapeutic strategies for inhibiting skin tumor progression.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...